CancerGRACE

cancergrace.org

 

Should We Continue the ALK Inhibitor in NSCLC Patient with Brain Mets and Progression in Body when Transitioning to a Chemo Based Approach?

March 13, 2020

0 Comments
Login to view comments. Click here to Login
Lung